SBFM
Sunshine Biopharma, Inc
Pharmaceutical PreparationsNasdaqNon-accelerated filer<br>Smaller reporting company
Total Trades
2
Buys
2
Sells
0
Largest Trade
$15K–$50K
Insiders
2
Institutional Funds
7
Inst. Value
$15K–$50K
Activist Filings
10
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Slilaty Steve N. | CEO | BUY | $1K–$15K | 20K | $0.10 | Feb 12, 2024 |
| Sebaaly Camille | CFO/Secretary | BUY | $15K–$50K | 30K | $0.76 | Dec 2, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 7 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Virtu Financial LLC | 23K | $15K–$50K | SH |
| MORGAN STANLEY | 11K | $1K–$15K | SH |
| SBI Securities Co., Ltd. | 5K | $1K–$15K | SH |
| UBS Group AG | 206 | <$1K | SH |
| Farther Finance Advisors, LLC | 1 | <$1K | SH |
| TD Waterhouse Canada Inc. | 1 | <$1K | SH |
| Strive Financial Group ,LLC | 1 | <$1K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Aug 14, 2025
0.0%
0 shares
SC 13G/A · Jun 13, 2025
0.0%
0 shares
SC 13G · May 23, 2025
10.0%
506K shares
SC 13G · Apr 11, 2025
8.2%
297K shares
L1 Capital Global Opportunities Master Fund, Ltd.
SC 13G/A · Feb 14, 2025
5.0%
142K shares
SC 13G/A · Nov 14, 2024
0.0%
0 shares
L1 Capital Global Opportunities Master Fund, Ltd.
SC 13G · Feb 23, 2024
5.3%
5.3M shares
Altium Capital Management, LP EIN 82-2066653
SC 13G · Feb 21, 2024
10.0%
3.7M shares
SC 13G · Feb 14, 2024
7.6%
2.1M shares
SC 13G · Nov 2, 2022
16.4%
3.7M shares